Ligand Pharmaceuticals Incorporated
—- Market cap
- $5.74B
- Debt
- —
- Cash
- −$174.93M
Complete market value, debt and cash evidence is required for enterprise value.
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
LGND · price snapshotP/E 46.99x
$288.05Snapshot Sep 9, 2026, 4:00 PM ET
Implied fair value · at HUM's multiple
$249.2013.5% below market
6.13 LGND Annual EPS×40.65x HUM P/E=$249.20
Market $288.05Implied $249.20
HUM · price snapshotP/E 40.65x
$400.02Snapshot Sep 9, 2026, 4:00 PM ET
Implied fair value · at LGND's multiple
$462.3815.6% above market
9.84 HUM Annual EPS×46.99x LGND P/E=$462.38
Market $400.02Implied $462.38